ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

BDRX Biodexa Pharmaceuticals PLC

1,0345
-0,0755 (-6,80%)
08 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Biodexa Pharmaceuticals PLC BDRX NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
-0,0755 -6,80% 1,0345 01:55:16
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,08 0,988 1,09 1,00 1,11
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202417:51GLOBEBiodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial..
26.4.202414:30GLOBEBiodexa Enters Into Exclusive License to eRapa™, a Phase 3..
19.4.202414:00GLOBEPreliminary Results for the Year Ended 31 December 2023
23.2.202414:30GLOBEBiodexa Announces Positive Top Line Phase I Clinical Trial..
13.2.202414:15APSBiotech Shares Bid Up Premarket Following 9.9% Institutional..
08.2.202414:30GLOBEBiodexa Reports 12 Month Survival in MAGIC-G1 Study of..
07.2.202414:30GLOBEBiodexa Announces Allowance of U.S. Patent Covering..
22.1.202414:30GLOBEBiodexa CEO Issues Shareholder Letter Highlighting Progress..
29.12.202310:05GLOBEBiodexa Appoints Ann Merchant to the Board of Directors
21.12.202322:00GLOBEBiodexa Announces Closing Of $6.0 Million Underwritten..
19.12.202314:42GLOBEBiodexa Announces Pricing of $5.2 Million Underwritten..
27.11.202315:00GLOBEBiodexa Enters Into Agreements to Acquire Exclusive..
03.10.202314:30GLOBEBiodexa Completes Recruitment of Cohort A in Study of MTX110..
29.9.202322:30GLOBEInterim results for the six months ended 30 June 2023
21.9.202314:30GLOBEBiodexa to Present Recruitment and Treatment Update in ..
28.7.202314:00GLOBEBiodexa Pharmaceuticals Launches New Corporate and Clinical..
24.7.202313:30GLOBEBiodexa Regain Compliance with NASDAQ Minimum Bid Price..
10.7.202314:00GLOBECompletion of Enrolment and Treatment in the Phase 1 Study..
06.7.202322:30GLOBEResults of Appeal of Delisting Determination
06.7.202314:15GLOBEPublication of Manuscript from the PNOC015 (a.k.a. MTD-201)..
22.6.202322:15GLOBEADR Ratio Change
20.6.202314:00GLOBEAppeal of Delisting Determination
15.6.202322:05GLOBEReceipt of NASDAQ Delisting Determination Plans to Appeal
14.6.202314:30GLOBEResults of Annual General Meeting and General Meeting
26.5.202322:05GLOBEBiodexa Pharmaceuticals PLC Announces Closing of $3.32..
24.5.202314:40GLOBEBiodexa Pharmaceuticals PLC Announces US$3.32 Million..
22.5.202322:15GLOBEPosting of Annual Report & Notice of AGM
18.5.202314:30GLOBEBiodexa Pharmaceuticals Enters into Non-binding Letter of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock